GT Biopharma, Inc.
GT Biopharma, Inc. GTBP.PA Peers
See (GTBP.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GTBP.PA | $280.50 | N/A | 626.73M | -4.10 | -$68.39 | N/A |
| ARGX.BR | $488.70 | -2.01% | 29.84B | 43.44 | $11.25 | N/A |
| UCB.BR | $156.65 | -1.07% | 29.77B | 28.59 | $5.48 | +0.89% |
| TUB.BR | $123.20 | N/A | 5.48B | 60.69 | $2.03 | +0.84% |
| GLPG.AS | $23.00 | +0.88% | 1.52B | -8.42 | -$2.73 | N/A |
| PHARM.AS | $0.87 | -0.11% | 592.89M | -43.57 | -$0.02 | N/A |
| MEDCL.PA | $15.05 | -1.18% | 497.68M | -13.81 | -$1.09 | N/A |
| VLA.PA | $2.90 | -0.62% | 484.39M | -36.22 | -$0.08 | N/A |
| ABVX.PA | $5.50 | -2.48% | 348.80M | -1.96 | -$2.80 | N/A |
| IVA.PA | $3.24 | +1.41% | 312.62M | -1.05 | -$3.08 | N/A |
Stock Comparison
GTBP.PA vs ARGX.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ARGX.BR has a market cap of 29.84B. Regarding current trading prices, GTBP.PA is priced at $280.50, while ARGX.BR trades at $488.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ARGX.BR's P/E ratio is 43.44. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ARGX.BR's ROE of +0.17%. Regarding short-term risk, GTBP.PA is more volatile compared to ARGX.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs UCB.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, UCB.BR has a market cap of 29.77B. Regarding current trading prices, GTBP.PA is priced at $280.50, while UCB.BR trades at $156.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas UCB.BR's P/E ratio is 28.59. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to UCB.BR's ROE of +0.11%. Regarding short-term risk, GTBP.PA is more volatile compared to UCB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs TUB.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, TUB.BR has a market cap of 5.48B. Regarding current trading prices, GTBP.PA is priced at $280.50, while TUB.BR trades at $123.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas TUB.BR's P/E ratio is 60.69. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to TUB.BR's ROE of +0.05%. Regarding short-term risk, GTBP.PA is more volatile compared to TUB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs GLPG.AS Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, GLPG.AS has a market cap of 1.52B. Regarding current trading prices, GTBP.PA is priced at $280.50, while GLPG.AS trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas GLPG.AS's P/E ratio is -8.42. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to GLPG.AS's ROE of -0.06%. Regarding short-term risk, GTBP.PA is more volatile compared to GLPG.AS. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs PHARM.AS Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, PHARM.AS has a market cap of 592.89M. Regarding current trading prices, GTBP.PA is priced at $280.50, while PHARM.AS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas PHARM.AS's P/E ratio is -43.57. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to PHARM.AS's ROE of -0.05%. Regarding short-term risk, GTBP.PA is more volatile compared to PHARM.AS. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs MEDCL.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, MEDCL.PA has a market cap of 497.68M. Regarding current trading prices, GTBP.PA is priced at $280.50, while MEDCL.PA trades at $15.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas MEDCL.PA's P/E ratio is -13.81. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to MEDCL.PA's ROE of +0.66%. Regarding short-term risk, GTBP.PA is more volatile compared to MEDCL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs VLA.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, VLA.PA has a market cap of 484.39M. Regarding current trading prices, GTBP.PA is priced at $280.50, while VLA.PA trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas VLA.PA's P/E ratio is -36.22. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to VLA.PA's ROE of -0.06%. Regarding short-term risk, GTBP.PA is more volatile compared to VLA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ABVX.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ABVX.PA has a market cap of 348.80M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ABVX.PA trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ABVX.PA's P/E ratio is -1.96. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ABVX.PA's ROE of -2.11%. Regarding short-term risk, GTBP.PA is more volatile compared to ABVX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs IVA.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, IVA.PA has a market cap of 312.62M. Regarding current trading prices, GTBP.PA is priced at $280.50, while IVA.PA trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas IVA.PA's P/E ratio is -1.05. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to IVA.PA's ROE of +1.98%. Regarding short-term risk, GTBP.PA is more volatile compared to IVA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs DBV.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, DBV.PA has a market cap of 265.78M. Regarding current trading prices, GTBP.PA is priced at $280.50, while DBV.PA trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas DBV.PA's P/E ratio is -1.92. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to DBV.PA's ROE of -1.64%. Regarding short-term risk, GTBP.PA is more volatile compared to DBV.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ORY.MC Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ORY.MC has a market cap of 203.76M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ORY.MC trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ORY.MC's P/E ratio is -37.57. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ORY.MC's ROE of -0.04%. Regarding short-term risk, GTBP.PA is more volatile compared to ORY.MC. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs GNFT.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, GNFT.PA has a market cap of 191.29M. Regarding current trading prices, GTBP.PA is priced at $280.50, while GNFT.PA trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas GNFT.PA's P/E ratio is 128.07. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to GNFT.PA's ROE of +0.02%. Regarding short-term risk, GTBP.PA is more volatile compared to GNFT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ONWD.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ONWD.BR has a market cap of 190.86M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ONWD.BR trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ONWD.BR's P/E ratio is -3.92. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ONWD.BR's ROE of -1.08%. Regarding short-term risk, GTBP.PA is more volatile compared to ONWD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs IPH.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, IPH.PA has a market cap of 183.39M. Regarding current trading prices, GTBP.PA is priced at $280.50, while IPH.PA trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas IPH.PA's P/E ratio is -3.26. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to IPH.PA's ROE of -2.63%. Regarding short-term risk, GTBP.PA is more volatile compared to IPH.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs HYL.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, HYL.BR has a market cap of 162.40M. Regarding current trading prices, GTBP.PA is priced at $280.50, while HYL.BR trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas HYL.BR's P/E ratio is -25.22. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to HYL.BR's ROE of -0.19%. Regarding short-term risk, GTBP.PA is more volatile compared to HYL.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs NANO.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, NANO.PA has a market cap of 158.53M. Regarding current trading prices, GTBP.PA is priced at $280.50, while NANO.PA trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas NANO.PA's P/E ratio is -2.34. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to NANO.PA's ROE of +0.77%. Regarding short-term risk, GTBP.PA is more volatile compared to NANO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs OSE.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, OSE.PA has a market cap of 135.74M. Regarding current trading prices, GTBP.PA is priced at $280.50, while OSE.PA trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas OSE.PA's P/E ratio is 3.52. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to OSE.PA's ROE of +0.52%. Regarding short-term risk, GTBP.PA is more volatile compared to OSE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALSEN.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALSEN.PA has a market cap of 111.48M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALSEN.PA trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALSEN.PA's P/E ratio is -4.12. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALSEN.PA's ROE of -0.33%. Regarding short-term risk, GTBP.PA is more volatile compared to ALSEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALCLS.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALCLS.PA has a market cap of 96.03M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALCLS.PA trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALCLS.PA's P/E ratio is -3.70. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALCLS.PA's ROE of -0.29%. Regarding short-term risk, GTBP.PA is more volatile compared to ALCLS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ADOC.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ADOC.PA has a market cap of 87.66M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ADOC.PA trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ADOC.PA's P/E ratio is -3.24. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ADOC.PA's ROE of +1.28%. Regarding short-term risk, GTBP.PA is more volatile compared to ADOC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs MAAT.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, MAAT.PA has a market cap of 83.15M. Regarding current trading prices, GTBP.PA is priced at $280.50, while MAAT.PA trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas MAAT.PA's P/E ratio is -2.35. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to MAAT.PA's ROE of -1.61%. Regarding short-term risk, GTBP.PA is more volatile compared to MAAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs TNG.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, TNG.PA has a market cap of 77.84M. Regarding current trading prices, GTBP.PA is priced at $280.50, while TNG.PA trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas TNG.PA's P/E ratio is -2.03. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to TNG.PA's ROE of -4.66%. Regarding short-term risk, GTBP.PA is more volatile compared to TNG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ERYP.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ERYP.PA has a market cap of 48.66M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ERYP.PA trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ERYP.PA's P/E ratio is -80.10. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ERYP.PA's ROE of -0.73%. Regarding short-term risk, GTBP.PA is more volatile compared to ERYP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs VVY.AS Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, VVY.AS has a market cap of 45.83M. Regarding current trading prices, GTBP.PA is priced at $280.50, while VVY.AS trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas VVY.AS's P/E ratio is -2.23. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to VVY.AS's ROE of -1.88%. Regarding short-term risk, GTBP.PA is more volatile compared to VVY.AS. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ABNX.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ABNX.PA has a market cap of 42.58M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ABNX.PA trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ABNX.PA's P/E ratio is -9.45. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ABNX.PA's ROE of -0.52%. Regarding short-term risk, GTBP.PA is more volatile compared to ABNX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs COX.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, COX.PA has a market cap of 29.04M. Regarding current trading prices, GTBP.PA is priced at $280.50, while COX.PA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas COX.PA's P/E ratio is -0.46. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to COX.PA's ROE of -0.43%. Regarding short-term risk, GTBP.PA is more volatile compared to COX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALGEN.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALGEN.PA has a market cap of 28.29M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALGEN.PA trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALGEN.PA's P/E ratio is 18.17. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALGEN.PA's ROE of +0.10%. Regarding short-term risk, GTBP.PA is more volatile compared to ALGEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs FALG.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, FALG.PA has a market cap of 23.95M. Regarding current trading prices, GTBP.PA is priced at $280.50, while FALG.PA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas FALG.PA's P/E ratio is -2.33. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to FALG.PA's ROE of -0.39%. Regarding short-term risk, GTBP.PA is more volatile compared to FALG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs DMSIM.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, DMSIM.BR has a market cap of 23.09M. Regarding current trading prices, GTBP.PA is priced at $280.50, while DMSIM.BR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas DMSIM.BR's P/E ratio is 0.09. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to DMSIM.BR's ROE of -0.57%. Regarding short-term risk, GTBP.PA is more volatile compared to DMSIM.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs POXEL.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, POXEL.PA has a market cap of 21.64M. Regarding current trading prices, GTBP.PA is priced at $280.50, while POXEL.PA trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas POXEL.PA's P/E ratio is -1.01. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to POXEL.PA's ROE of +0.32%. Regarding short-term risk, GTBP.PA is more volatile compared to POXEL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALDVI.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALDVI.PA has a market cap of 21.48M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALDVI.PA trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALDVI.PA's P/E ratio is -2.33. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALDVI.PA's ROE of +0.44%. Regarding short-term risk, GTBP.PA is more volatile compared to ALDVI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs CYAD.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, CYAD.BR has a market cap of 18.64M. Regarding current trading prices, GTBP.PA is priced at $280.50, while CYAD.BR trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas CYAD.BR's P/E ratio is -0.33. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to CYAD.BR's ROE of +0.91%. Regarding short-term risk, GTBP.PA is more volatile compared to CYAD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALVAL.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALVAL.PA has a market cap of 17.31M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALVAL.PA trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALVAL.PA's P/E ratio is -1.73. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALVAL.PA's ROE of -0.74%. Regarding short-term risk, GTBP.PA is more volatile compared to ALVAL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALNFL.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALNFL.PA has a market cap of 17.11M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALNFL.PA trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALNFL.PA's P/E ratio is -8.01. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALNFL.PA's ROE of -1.27%. Regarding short-term risk, GTBP.PA is more volatile compared to ALNFL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs AELIS.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, AELIS.PA has a market cap of 16.72M. Regarding current trading prices, GTBP.PA is priced at $280.50, while AELIS.PA trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas AELIS.PA's P/E ratio is -2.22. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to AELIS.PA's ROE of -0.74%. Regarding short-term risk, GTBP.PA is more volatile compared to AELIS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALPHE.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALPHE.PA has a market cap of 15.83M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALPHE.PA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALPHE.PA's P/E ratio is -2.67. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALPHE.PA's ROE of -0.64%. Regarding short-term risk, GTBP.PA is more volatile compared to ALPHE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALPAT.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALPAT.PA has a market cap of 12.34M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALPAT.PA trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALPAT.PA's P/E ratio is 11.11. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALPAT.PA's ROE of +0.01%. Regarding short-term risk, GTBP.PA is more volatile compared to ALPAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs BAI.AS Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, BAI.AS has a market cap of 11.25M. Regarding current trading prices, GTBP.PA is priced at $280.50, while BAI.AS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas BAI.AS's P/E ratio is -0.13. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to BAI.AS's ROE of -0.51%. Regarding short-term risk, GTBP.PA is more volatile compared to BAI.AS. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALVET.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALVET.PA has a market cap of 10.02M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALVET.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALVET.PA's P/E ratio is -0.17. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALVET.PA's ROE of -0.32%. Regarding short-term risk, GTBP.PA is more volatile compared to ALVET.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALVIO.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALVIO.PA has a market cap of 9.95M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALVIO.PA trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALVIO.PA's P/E ratio is -0.46. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALVIO.PA's ROE of -2.09%. Regarding short-term risk, GTBP.PA is more volatile compared to ALVIO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs APM.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, APM.PA has a market cap of 8.82M. Regarding current trading prices, GTBP.PA is priced at $280.50, while APM.PA trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas APM.PA's P/E ratio is -0.71. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to APM.PA's ROE of +0.08%. Regarding short-term risk, GTBP.PA is more volatile compared to APM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALTME.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALTME.PA has a market cap of 6.93M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALTME.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALTME.PA's P/E ratio is -0.60. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALTME.PA's ROE of -8.99%. Regarding short-term risk, GTBP.PA is more volatile compared to ALTME.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALTHX.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALTHX.PA has a market cap of 5.08M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALTHX.PA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALTHX.PA's P/E ratio is -3.89. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALTHX.PA's ROE of +7.08%. Regarding short-term risk, GTBP.PA is more volatile compared to ALTHX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALQGC.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALQGC.PA has a market cap of 5.00M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALQGC.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALQGC.PA's P/E ratio is -0.09. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALQGC.PA's ROE of +14.01%. Regarding short-term risk, GTBP.PA is more volatile compared to ALQGC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs LYS.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, LYS.PA has a market cap of 4.95M. Regarding current trading prices, GTBP.PA is priced at $280.50, while LYS.PA trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas LYS.PA's P/E ratio is -0.64. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to LYS.PA's ROE of -11.30%. Regarding short-term risk, GTBP.PA is more volatile compared to LYS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALINT.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALINT.PA has a market cap of 3.97M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALINT.PA trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALINT.PA's P/E ratio is -15.00. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALINT.PA's ROE of -0.14%. Regarding short-term risk, GTBP.PA is more volatile compared to ALINT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALHYG.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALHYG.PA has a market cap of 3.95M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALHYG.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALHYG.PA's P/E ratio is -0.26. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALHYG.PA's ROE of -6.80%. Regarding short-term risk, GTBP.PA is more volatile compared to ALHYG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALACT.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALACT.PA has a market cap of 3.94M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALACT.PA trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALACT.PA's P/E ratio is -0.22. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALACT.PA's ROE of +1.38%. Regarding short-term risk, GTBP.PA is more volatile compared to ALACT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALBPS.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALBPS.PA has a market cap of 3.45M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALBPS.PA trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALBPS.PA's P/E ratio is -0.04. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALBPS.PA's ROE of +1.88%. Regarding short-term risk, GTBP.PA is more volatile compared to ALBPS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs GNRO.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, GNRO.PA has a market cap of 2.03M. Regarding current trading prices, GTBP.PA is priced at $280.50, while GNRO.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas GNRO.PA's P/E ratio is -0.12. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to GNRO.PA's ROE of +2.39%. Regarding short-term risk, GTBP.PA is more volatile compared to GNRO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALMDP.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALMDP.PA has a market cap of 1.77M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALMDP.PA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALMDP.PA's P/E ratio is -0.59. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALMDP.PA's ROE of +0.40%. Regarding short-term risk, GTBP.PA is more volatile compared to ALMDP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALDEI.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALDEI.PA has a market cap of 1.13M. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALDEI.PA trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALDEI.PA's P/E ratio is -0.11. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALDEI.PA's ROE of +0.61%. Regarding short-term risk, GTBP.PA is more volatile compared to ALDEI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs BIOS.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, BIOS.BR has a market cap of 1.11M. Regarding current trading prices, GTBP.PA is priced at $280.50, while BIOS.BR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas BIOS.BR's P/E ratio is -0.04. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to BIOS.BR's ROE of +0.34%. Regarding short-term risk, GTBP.PA is more volatile compared to BIOS.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs OVXA.IR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, OVXA.IR has a market cap of 856420.00. Regarding current trading prices, GTBP.PA is priced at $280.50, while OVXA.IR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas OVXA.IR's P/E ratio is -0.21. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to OVXA.IR's ROE of -0.00%. Regarding short-term risk, GTBP.PA is more volatile compared to OVXA.IR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs OXUR.BR Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, OXUR.BR has a market cap of 321214.00. Regarding current trading prices, GTBP.PA is priced at $280.50, while OXUR.BR trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas OXUR.BR's P/E ratio is N/A. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to OXUR.BR's ROE of -0.01%. Regarding short-term risk, GTBP.PA is more volatile compared to OXUR.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALNEV.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALNEV.PA has a market cap of 17346.00. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALNEV.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALNEV.PA's P/E ratio is N/A. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALNEV.PA's ROE of -1.23%. Regarding short-term risk, GTBP.PA is more volatile compared to ALNEV.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.
GTBP.PA vs ALPHA.PA Comparison
GTBP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBP.PA stands at 626.73M. In comparison, ALPHA.PA has a market cap of 1190.00. Regarding current trading prices, GTBP.PA is priced at $280.50, while ALPHA.PA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBP.PA currently has a P/E ratio of -4.10, whereas ALPHA.PA's P/E ratio is -0.00. In terms of profitability, GTBP.PA's ROE is -4.68%, compared to ALPHA.PA's ROE of +0.83%. Regarding short-term risk, GTBP.PA is more volatile compared to ALPHA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBP.PA.